Evidence Hub

Abstracts for oral sessions

CARBONI, LUCIA, Piubelli C., Domenici E., El Khoury A., Gruber S., Andersson W., Vollmayr B., Gass P. et al.

European Psychiatry, 2006

Abstract

Conflict of interest in science has emerged as a major issue of concern in the past decade.The credibility of clinical medicine (including psychiatry) has come to an unprecedented crisis, due to the proliferation of connections between physicians and pharmaceutical industry.Studies sponsored by pharmaceutical companies are more likely to have outcomes favorable to the sponsor, to entail restrictions on publication and data sharing, and result in selective reporting.Further, most of the negative trials concerned with psychotropic drugs do not get published.Investigators conducting a clinical trial in psychopharmacology are thus confronted with major ethical issues related to conflict of interest.Similar considerations apply to the researchers performing metaanalyses or literature reviews.Suggestions for decreasing the bias derived from conflict of interest in clinical psychopharmacology and for developing ethical guidelines for investigators will be discussed. PL04.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free